CTOs on the Move

Milestone Scientific

www.milestone.com

 
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone`s computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone`s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.milestone.com
  • 425 Eagle Rock Avenue Suite 403
    Roseland, NJ USA 07068
  • Phone: 973.535.2717

Executives

Name Title Contact Details

Similar Companies

Applied Clinical Research Institute

Applied Clinical Research Institute is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Ultrasound Electronics

Advanced Ultrasound Electronics is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Achoo Allergy and Air Products

Achoo Allergy and Air Products is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Central Anesthesia Service Exchange Medical Group Inc

Central Anesthesia Service Exchange Medical Group Inc is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.